The British Journal of Cancer issued a formal retraction of a study examining Circular RNA 0000096 in gastric cancer after identifying issues that undermined the paper’s findings. The notice withdraws prior claims about the RNA’s role in tumor biology and signals heightened editorial scrutiny around reproducibility in molecular oncology. Researchers and clinicians are urged to re‑evaluate downstream work that cited the retracted study; the incident underscores ongoing concerns about data integrity in high‑impact translational research.